Skip to main content
. 2021 Jun 25;10(13):e019212. doi: 10.1161/JAHA.120.019212

Figure 3. Meta‐analysis of the safety of the leadless pacemaker (LP).

Figure 3

A, Pooled incidence of overall complications at up to 90 days after LP implantation. B, Pooled incidence of overall complications at ≈1 year after LP implantation in studies that reported safety outcomes beyond 90 days. C, Incidence of overall complications in studies that compared the LP with the transvenous pacemaker (TVP) implantation. *Vaidya et al44 reported complications for both Nanostim (17 patients) and Micra LPs (73 patients) compared with those associated with a TVP (90 patients). OR indicates odds ratio.